MANILA, Philippines — GSK plc (LSE/NYSE: GSK) has today released global survey data showing that over half (52%) of people aged 50-60 feel younger than their age—and nearly a fifth (19% ...

GSK’s boss has joined other industry chiefs warning the UK and Europe need to ‘do more’ to support the industry or risk losing jobs and investment cash to the US. The pharma giant’s chief ...

Ladies and gentlemen, a very warm welcome to this GSK Q1 2025 Results Call. My name is Constantin Fest, new head of IR at GSK, and I'm delighted to be joined today by Emma Walmsley, Luke Miels and ...

GSK and Smith & Nephew outperformed forecast-beating Barclays today as the FTSE 100 index stayed within reach of a 13th consecutive improvement. London’s top flight stood 5.10 points lower at ...

U.K.-based drugmaker GSK, formerly known as GlaxoSmithKline, has said it is “well positioned” to cope with any financial impact from changes to U.S. tariff rules. The company maintained its financial ...

In 2024, GlaxoSmithKline withdrew Flovent from the market. The inhaler was commonly prescribed to prevent asthma attacks in children. The pharma company continued to sell a chemically identical ...

The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates and assets, including Merck’s Keytruda and GSK’s Jemperli. The American ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the ...

And even though the price has recovered from that dip, it’s still down 11% year to date. GSK reported a 2% revenue rise at actual exchange rates (4% at constant rates), driven largely by a 17% ...

GSK (NYSE:GSK) reported Q1 2025 results on Wednesday, narrowly beating analysts’ estimates as the British drugmaker’s Specialty Medicines business offset weakness in its Vaccine and General ...

Stock Market Today: The Benchmark Nifty-50 index, on a cautious note, ended almost flat (up 0.03%) at 24,335.95 on Tuesday. The Bank Nifty at 55,391.29 also ended marginally lower though metals ...

GSK (GSK) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.09 per share a year ago. These figures are ...